Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (471-480 of 487) with videos related to

Pageof 49
Sort By:
Blood|September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITPEun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Nature Immunology|August 3, 2010
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88Bing He, Raul Santamaria, Weifeng Xu, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2018
Screening for Wiskott-Aldrich syndrome by flow cytometrySamuel C C Chiang, Sue M Vergamini, Ammar Husami, et al.
Blood|October 23, 2009
International consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Roberto Stasi, Adrian C Newland, et al.
Blood Advances|April 5, 2022
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutationsHaiyu Zhang, May Chien, Yu Hou, et al.
Blood|February 7, 2023
The role of CD8+ T-cell clones in immune thrombocytopeniaAmna Malik, Anwar A Sayed, Panpan Han, et al.
Pageof 49

Showing results (471-480 of 487) with videos related to

Sort By:
Pageof 49
Blood|September 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITPEun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari, et al.
The Lancet. Haematology|December 22, 2015
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled studyJames B Bussel, Purificación Garcia de Miguel, Jenny M Despotovic, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Nature Immunology|August 3, 2010
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88Bing He, Raul Santamaria, Weifeng Xu, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2018
Screening for Wiskott-Aldrich syndrome by flow cytometrySamuel C C Chiang, Sue M Vergamini, Ammar Husami, et al.
Blood|October 23, 2009
International consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Roberto Stasi, Adrian C Newland, et al.
Blood Advances|April 5, 2022
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutationsHaiyu Zhang, May Chien, Yu Hou, et al.
Blood|February 7, 2023
The role of CD8+ T-cell clones in immune thrombocytopeniaAmna Malik, Anwar A Sayed, Panpan Han, et al.
Pageof 49